Literature DB >> 28836174

Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.

Leili Pourafkari1,2, Kourosh Masnadi-Shirazi1, Mohammadreza Taban3, Solmaz Mohammadi1, Razieh Parizad3, Samad Ghaffari3, Arezou Tajlil3, Mir Milad Pourmousavi Khoshknab3, Nader D Nader4.   

Abstract

BACKGROUND: Masked hypertension (MHTN) and lack of nocturnal dipping in blood pressure (BP) have been linked to the state of inflammation. AIMS: We aimed to assess the frequency of nocturnal patterns of BP and heart rate (HR) in patients with IBD.
METHODS: Sixty-three normotensive patients with confirmed IBD during remission and 63 healthy subjects were enrolled in a case-control study. All subjects were monitored for BP and HR over a period of 24 h under ambulatory setting. Means for BP and HR were calculated for nighttime and daytime periods. Daytime BP ≥ 135/85 mmHg, nighttime BP ≥ 120/70 mmHg, and 24-h average BP ≥ 130/80 mmHg were defined as MHTN. The main end points of this study were lack of >10% nocturnal decrease in the systolic BP (NDP-BP) and in HR (NDP-HR).
RESULTS: After exclusion of 8 patients with IBD from analysis, 55 patients and 63 control subjects (49% men) with a mean age of 37.5 ± 11.0 years were enrolled. NDP-BP was more common in the IBD group compared to controls (55 vs. 33%; P = 0.026). MHTN was detected in 24% of IBD patients compared to 8% among controls (P = 0.017). Meanwhile, NDP-HR was observed in 22% of the IBD patients and 30% of the control group (P = 0.402). IBD remained a significant predictor of NDP-BP (odds ratio 2.60, 95% confidence interval 1.19-5.51) following an adjustment for age and gender.
CONCLUSIONS: IBD is associated with higher frequency of NDP-BP and MHTN; however, nocturnal changes in HR were similar in both groups.

Entities:  

Keywords:  Blood pressure; Blood pressure monitoring; Inflammatory bowel disease; Masked hypertension; Ulcerative colitis

Mesh:

Year:  2017        PMID: 28836174     DOI: 10.1007/s10620-017-4712-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  European Society of Hypertension position paper on ambulatory blood pressure monitoring.

Authors:  Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2013-09       Impact factor: 4.844

2.  Impact of obesity on 24-hour ambulatory blood pressure and hypertension.

Authors:  Vasilios Kotsis; Stella Stabouli; Marshall Bouldin; Annette Low; Savvas Toumanidis; Nikos Zakopoulos
Journal:  Hypertension       Date:  2005-02-21       Impact factor: 10.190

3.  Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study.

Authors:  Riitta-Liisa Vasunta; Y Antero Kesäniemi; Antti Ylitalo; Olavi Ukkola
Journal:  Am J Hypertens       Date:  2011-08-25       Impact factor: 2.689

4.  Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.

Authors:  Andres J Yarur; Amar R Deshpande; David M Pechman; Leonardo Tamariz; Maria T Abreu; Daniel A Sussman
Journal:  Am J Gastroenterol       Date:  2011-03-08       Impact factor: 10.864

5.  Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations.

Authors:  Y Imai; K Abe; S Sasaki; N Minami; M Munakata; M Nihei; H Sekino; K Yoshinaga
Journal:  J Hypertens       Date:  1989-02       Impact factor: 4.844

Review 6.  Dipping pattern of nocturnal blood pressure in patients with hypertension.

Authors:  Robert H Fagard
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-06

7.  Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.

Authors:  Guo-Cui Wu; Rui-Xue Leng; Qi Lu; Yin-Guang Fan; De-Guang Wang; Dong-Qing Ye
Journal:  Angiology       Date:  2016-06-01       Impact factor: 3.619

8.  Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension.

Authors:  Osman Turak; Fırat Ozcan; Derya Tok; Ahmet Işleyen; Erdoğan Sökmen; Irfan Taşoğlu; Sinan Aydoğdu; Nihat Sen; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-11-02       Impact factor: 3.738

9.  Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levels.

Authors:  Dimitris P Papadopoulos; Iordanis Mourouzis; Charles Faselis; Despina Perrea; Thomas Makris; Costas Tsioufis; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-12       Impact factor: 3.738

10.  Blood pressure reverse dipping may associate with stable coronary artery disease in patients with essential hypertension: a cross-sectional study.

Authors:  Bin Yan; Lu Sun; Ya Gao; Qi Guo; Litao Guo; Xue Wang; Gang Wang
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

View more
  2 in total

1.  Association of nocturnal blood pressure patterns with inflammation and central and peripheral estimates of vascular health in rheumatoid arthritis.

Authors:  Eugenia Gkaliagkousi; Panagiota Anyfanti; Sophia Chatzimichailidou; Areti Triantafyllou; Antonios Lazaridis; Spyros Aslanidis; Stella Douma
Journal:  J Hum Hypertens       Date:  2018-03-09       Impact factor: 3.012

2.  Effect of Probiotic Therapy on Hemodynamic Response Associated with Systemic Inflammatory Reaction and Antibiotic-Induced Dysbiosis in Chronic Experiments in Rats.

Authors:  Yu Yu Borshchev; E S Protsak; I Yu Burovenko; N Yu Semenova; I G Zubkov; M M Galagudza
Journal:  Bull Exp Biol Med       Date:  2022-05-02       Impact factor: 0.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.